Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amicus Therapeutics (FOLD) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Amicus Therapeutics (FOLD) over the last 15 years, with Q3 2025 value amounting to 0.15%.

  • Amicus Therapeutics' Return on Invested Capital fell 1700.0% to 0.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.15%, marking a year-over-year decrease of 1700.0%. This contributed to the annual value of 0.09% for FY2024, which is 2300.0% up from last year.
  • Latest data reveals that Amicus Therapeutics reported Return on Invested Capital of 0.15% as of Q3 2025, which was down 1700.0% from 0.06% recorded in Q2 2025.
  • Over the past 5 years, Amicus Therapeutics' Return on Invested Capital peaked at 0.7% during Q1 2025, and registered a low of 0.47% during Q3 2022.
  • Over the past 5 years, Amicus Therapeutics' median Return on Invested Capital value was 0.25% (recorded in 2023), while the average stood at 0.18%.
  • Per our database at Business Quant, Amicus Therapeutics' Return on Invested Capital tumbled by -1700bps in 2022 and then soared by 8300bps in 2025.
  • Over the past 5 years, Amicus Therapeutics' Return on Invested Capital (Quarter) stood at 0.29% in 2021, then plummeted by -36bps to 0.4% in 2022, then surged by 64bps to 0.15% in 2023, then soared by 158bps to 0.08% in 2024, then plummeted by -281bps to 0.15% in 2025.
  • Its last three reported values are 0.15% in Q3 2025, 0.06% for Q2 2025, and 0.7% during Q1 2025.